Implantable cardioverter defibrillator
Implantable cardioverter defibrillator (ICD) was indicated in type-1 BrS patients with syncope presumed to be of arrhythmic origin, aborted sudden cardiac death or induced sustained VT/VF in EPS.7 In this sample, visits after ICD were scheduled for 1, 3 and 6 months, and every 6 months after that.